Tactile Systems Technology, Inc. (NASDAQ:TCMD – Get Rating) Director William W. Burke sold 1,100 shares of the company’s stock in a transaction dated Thursday, May 19th. The shares were sold at an average price of $10.12, for a total transaction of $11,132.00. Following the sale, the director now owns 19,536 shares of the company’s stock, valued at $197,704.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of TCMD stock traded down $0.04 on Monday, hitting $9.50. The stock had a trading volume of 747,864 shares, compared to its average volume of 229,623. Tactile Systems Technology, Inc. has a 12-month low of $9.48 and a 12-month high of $57.64. The business has a 50 day moving average of $16.86 and a 200 day moving average of $18.46. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.56 and a quick ratio of 2.08. The stock has a market cap of $189.42 million, a price-to-earnings ratio of -7.54 and a beta of 1.40.

Tactile Systems Technology (NASDAQ:TCMD – Get Rating) last announced its earnings results on Tuesday, February 22nd. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.34). The company had revenue of $61.73 million for the quarter, compared to the consensus estimate of $58.22 million. Tactile Systems Technology had a negative net margin of 11.78% and a negative return on equity of 12.31%. During the same quarter in the previous year, the firm earned $0.61 earnings per share. As a group, research analysts expect that Tactile Systems Technology, Inc. will post -0.49 earnings per share for the current fiscal year.

A number of institutional investors have recently made changes to their positions in the stock. Marshall Wace North America L.P. bought a new position in Tactile Systems Technology during the 1st quarter valued at about $25,000. PNC Financial Services Group Inc. lifted its stake in Tactile Systems Technology by 219.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 2,016 shares of the company’s stock valued at $40,000 after acquiring an additional 1,385 shares during the period. Advisor Group Holdings Inc. lifted its stake in Tactile Systems Technology by 20.3% during the 3rd quarter. Advisor Group Holdings Inc. now owns 2,546 shares of the company’s stock valued at $113,000 after acquiring an additional 429 shares during the period. KBC Group NV lifted its stake in Tactile Systems Technology by 315.7% during the 3rd quarter. KBC Group NV now owns 2,939 shares of the company’s stock valued at $131,000 after acquiring an additional 2,232 shares during the period. Finally, Banque Cantonale Vaudoise purchased a new stake in shares of Tactile Systems Technology during the 1st quarter valued at about $81,000. Institutional investors own 92.58% of the company’s stock.

TCMD has been the subject of several research reports. BTIG Research reduced their target price on shares of Tactile Systems Technology from $44.00 to $29.00 in a research note on Wednesday, February 23rd. StockNews.com began coverage on shares of Tactile Systems Technology in a research report on Thursday, March 31st. They issued a “hold” rating for the company. TheStreet lowered shares of Tactile Systems Technology from a “c-” rating to a “d” rating in a report on Wednesday, February 23rd. Finally, Piper Sandler dropped their price objective on shares of Tactile Systems Technology from $40.00 to $28.00 in a report on Wednesday, February 23rd. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $38.00.

Tactile Systems Technology Company Profile (Get Rating)

Tactile Systems Technology, Inc, a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders.

Further Reading

Receive News & Ratings for Tactile Systems Technology Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Tactile Systems Technology and related companies with MarketBeat.com’s FREE daily email newsletter.